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Abstract
Hyperkalaemia is a common electrolyte disorder with
potentially lethal consequences and can lead to life-threatening
cardiac dysrhythmias. Spurious hyperkalaemia, also known as
pseudohyperkalaemia or factitious hyperkalaemiais, is also
quite common in clinical practice and it's a source of avoidable
emergency department visits or hospital admissions. We report
a case in which alarming hyperkalaemia was found in a patient
having Chronic Monomyelocytic Leukaemia on two different
occasions, later diagnosed to be spurious. 
Keywords: Spurious Hyperkalaemia, Cardiac dysrhythmia.
Introduction
Spurious hyperkalaemia is a clinical condition in
which there is an artifactual elevation of the serum potassium
level due to a variety of possible causes.1 It is defined as the
serum potassium concentration exceeds that of plasma by
more than 0.4mmol/l, provided that sample is collected under
strict techniques, remain at room temperature and are tested
within an hour from blood specimen collection.2 Spurious
hyperkalaemia can cause major difficulties in primary care
and is a source of avoidable emergency referral and even
admission to hospital. Laboratory analysis requires proper
specimen collection, identification, processing, and chemical
analysis. A failure in the first several steps (the incorrect
sample collection or its mislabeling, etc.) usually is a clerical
error that will be discovered and corrected when the test is
repeated. However, if the test is abnormal due to an artifact
which is unique to the laboratory test, then the error will be
recognized only if the physician recognizes potential pitfalls
associated with a particular test.3 We report a patient with
Chronic Monomyelocytic leukaemia who presented with
spuriously high level of potassium that lead to inappropriate
intervention.
Case Report
A 78 year old lady with hypertension, diabetes
mellitus, mild chronic kidney disease (CKD) (glomerular
filtration rate of 30 ml/min) and Chronic Myelomonocytic
Leukaemia (CMML), was admitted for the management of
hyperkalaemia, which was revealed on routine laboratory
investigations with serum potassium of 7.3 mmol/l and serum
creatinine of 2.0mg/dl. She was recently started on Losartan
Potassium 50mg once daily and was neither on potassium
supplement nor receiving any chemotherapy. Vitally she was
stable, except for mild pedal oedema and mild splenomegaly,
the physical examination was unremarkable. The other
laboratory investigations were done which showed
haemoglobin of 16g/dl, white blood cells; 40,600, platelets:
775,000, LDH: 81, serum uric acid: 11.6 mmol/l, serum
calcium, phosphate, other electrolytes, short synacthen test for
cortisol and detailed report of urine were normal with normal
ECG findings. She was treated with insulin, dextrose and
calcium gluconate infusion and also given Kayexalate. Her
serum potassium came down to 5.1mmol/l. Losartan was
supposed to be the cause of hyperkalaemia and thus stopped
and she was discharged with the diagnosis of Angiotensin
receptor antagonist (ARB) induced Hyperkalaemia with
CKD. After a month, the routine follow up investigation
showed serum potassium of 7.5mmol/l with serum creatinine
of 1.5mg/dl. This time again, she was asymptomatic and was
managed for hyperkalaemia in hospital. Her lab investigation
showed haemoglobin of 14.8gm/dl, WBC: 39600,
neutrophils: 71.8%, lymphocytes: 11.2%, monocytes: 14%
and platelets: 1175000. Due to severe leucocytosis and
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thrombocytosis and no obvious reason for hyperkalaemia, a
suspicion of spuriouis hyperkalaemia was raised. Two
samples were checked for potassium simultaneously one with
clotted blood and other in heparinized tube. The clotted
sample showed serum potassium of 5.2mmol/l, while
simultaneous heparinized samle showed serum potassium of
3.9mmol/l. This suggested that hyperkalaemia in this patient
was spurious due to severe laucocytosis and thrombocytosis.
This patient fortunately, despite of being treated for
spuriously high level of potassium, remained asymptomatic
and went home with haematological follow up for CMML.
The reason for highlighting this case is to bring physician's
attention and to have a high index of suspicion for spurious
hyperkalaemia in asymptomatic patients, especially in the
presence of severe leukocytosis, thrombocytosis and other
causes of spurious hyperkalaemia which are discussed.
Discussion
The spurious hyperkalaemia in most cases is due to
technical reasons (collection, transport or storage) and clerical
(mislabeling of sample).4 These errors can be corrected when
the sample is repeated. However, the main problem arises
when the spurious result is technically accurate but does not
reflect the true patient's condition. There are various
haematological disorders like in vitro haemolysis and high cell
count which can produce spurious results.3 In our patient the
spurious hyperkalaemia was due to CMML which was
initially considered as true, leading to inappropriate
management of the patient. Various causes of spurious
hyperkalaemia are shown in Table-1.5
In asymptomatic patients the presence of spurious
hyperkalaemia should be suspected whenever there is no
apparent cause for the elevation of serum potassium
concentration. Haemolysis, traumatic venipuncture,
prolonged or tight tourniquet application can subsequently
increase serum potassium level by its release from blood cell
and skeletal muscle into blood stream. Measurement of the
repeat plasma potassium concentration after proper technique,
usually establishes the correct diagnosis.1 Similarly, repeated
clenching and unclenching of the fist may artifactually
increase the potassium concentration by as much as 1-2
mmol/l . The above conditions were excluded in our patient.
In some cases, potassium release on coagulation is
exaggerated. This happens, for example, in hereditary or
acquired stomatocytosis. Dehydrated hereditary
stomatocytosis (DHS) is a rare dominant form of hereditary
haemolytic anaemia. In some families, spurious
hyperkalaemia accompanies DHS.6 This rare familial
condition is characterized by a temperature-dependent loss of
potassium from RBCs when stored at room temperature. In
these situations an anticoagulated sample taken for analysis of
plasma potassium will show a significantly higher than normal
difference between the plasma and serum concentrations
(typically about 0.3 mmol/l) than in the coagulated sample.
Anticoagulation reduces the leakage of potassium that occurs
on clotting and will produce a more physiological result.
Lithium heparin is the recommended anticoagulant; plasma
potassium EDTA (full blood count tube) should be avoided.5
Normally, the serum potassium concentration is
typically 0.1-0.4 meq/l greater than that measured in a plasma
sample in which clotting is prevented by drawing the blood
into a heparinized tube. In patients with leukaemia or
myeloproliferative disease this phenomenon becomes
exaggerated7 where there is a marked elevation of the WBC
count (>100 000/mm3) or platelet count (>1 000 000/mm3). It
is estimated that for every 100 X 10 (9)/ L of platelets, an
increase of 0.07 to 0.15 mmol/L of potassium is expected.
Therefore in thrombocytosis, plasma rather than serum
potassium should be measured. Reverse pseudohyperkalaemia
has also been reported to occur in patients with
haematological malignancies in whom the plasma potassium
levels are greater than the serum potassium levels. The
difference between serum and plasma potassium
concentration (Dk) is increased in patients with
erythrocytoses, thrombocytoses or both. This phenomenon is
more profound in patients with a mixed type disorder, such as
polycythemia vera patients, compared to those with
erythrocytoses alone.8 This can be identified by checking the
sample in lithium heparin.
Hyperkalaemia is most likely spurious if the patient
has normal renal function and there is no predisposing factors
like potassium supplement, drugs that raise potassium or
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Table-1: Related to collection and storage of specimen.
Difficulty in collecting sample or traumatic venepunture
Repeated clenching of fist when sample taken
Sample was shaken or squirted through needle into collection tube
Contamination with anticoagulant from another sample (potassium EDTA)
Cooling
Deterioration of specimen due to length of storage
Drawing sample from the vein or line where potassium being infused
Pre-existing conditions
Thrombocytosis
Severe leucocytosis
Hereditary and acquired red cell disorders
Information from reference 3.
Table-2: Identify patients with risk for true Hyperkalaemia.
Patients with known Chronic Kidney Disease
May be on Drugs like Angiotensin Converting Enzyme inhibitor,
Angiotensin Receptor blocker, Potassium sparing diuretics, NSAIDs,
Corticosteroids 
Patients with clinical features such as myopathy, paralysis, arrhythmias,
bradycardia
Patients with acute illness (acute renal failure, ketoacidosis, etc)
*Consider spurious hyperkalaemia in the absence of all the above.
combination of potassium raising drugs.9 Table-2 points out
the factors which indicates true hyperkalaemina.
Conclusion
Hyperkalaemia, a life threatening condition, need not
always be a truly raised potassium disorder. Spurious
hyperkalaemia should be considered, especially when the
patient is asymptomatic with no obvious reason for raised
potassium levels, to avoid unnecessary treatment and hospital
admission. Conditions leading to Spurious hypokalaemia
including severe leucocytosis and thrombocytosis, should be
known to all physicians especially those working in the
emergency room.
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